Summary
Overview
Work History
Education
Skills
Languages
Timeline
Generic
Miloš Repše

Miloš Repše

Bad Häring

Summary

Agile and competent Regulatory Leader with 14+ years of experience in Pharmaceutical and Biotech Industry. Strong ability to lead a team in fast changing environment and to influence without authority.

Overview

13
13
years of professional experience

Work History

RA CMC Associate Director Biosimilars

Sandoz
10.2022 - Current
  • Regulatory CMC Project lead for a designated product/project
  • Formulate, lead and drive global CMC regulatory strategy and all global CMC submission activities ) for assigned projects
  • Coordinate and communicate CMC regulatory strategies, risks and key issues with project teams and other stakeholders
  • Initiate and lead Health Authority interactions and negotiations; preparing briefing books


Accomplishments:

  • As RPL for GP17/GPN017 I coordinated the CMC regulatory team of 9 Managers
  • Responsible for US/EU approval of HCF, successful roll out to other highly regulated markets HRMs (UK, AU, CH....) and for the roll out globally.
  • Tackled the variation backlog on LCF to prevent supply shortage on the market

Due Diligence Director Biopharma - Rotation

Sandoz
07.2024 - 01.2025
  • Support DD lead in coordinating and leading 2 Due Diligence projects including supporting scientific discussions, organizing sub-workstreams, leading interactions with the team and external partner, helping with preparation of the meeting materials
  • Support DD lead with early assessments of DD opportunities
  • Involved in OpEx initiatives, including preparation of working templates and creating training materials


Head Development Regulatory Center

Sandoz
02.2020 - 10.2022
  • Head of Sandoz Small molecule RA CMC department
  • Leading, directing and motivating the team
  • Implementation and follow-up of development plans
  • Supporting Development Center on execution of new allocated products and strategic projects
  • Coaching and training of the DRC staff with respect to global regulatory requirements and key competencies
  • Establishing efficient team organization and working methods in accordance with internal Sandoz guidelines and standards
  • Providing best in class regulatory input to relevant stakeholders for decisions making


Accomplishments:

  • Responsible for building up the team of 10 CMC managers, with the focus on the Sandoz values
  • Active role in the transformation - Successful migration of the projects from the closing development sites
  • Responsible for around 7 major (US/CA/EU) new submissions per year

Head of Regulatory New Submissions

Sandoz
11.2017 - 02.2020
  • Group Head of Sandoz Small molecule RA CMC department
  • Lead a team of 10+ employees including target setting, control of efficiency, motivation and coaching of the team members
  • Functionally lead registration team of B2B including contribution to target setting, control of efficiency and motivation and coaching of team members
  • General management - organization, capacity planning and decision taking
  • Setting of regulatory strategy for new development products, established products and products sold to third parties
  • Organize in-time delivery of regulatory strategies and compilation of all registration dossiers (M2 - M5) for new submissions and renewals (US, EU, worldwide)


Accomplishments:

  • Several CA/US submissions/approval of mainly legacy anti-infective products
  • Introducing efficient team set-up sharing the capacities with the LCM group
  • Supporting and guiding team in times of transformation (closing of MRC in Kundl late 2019)

CMC facilitator/Regulatory Specialist

Novartis
12.2016 - 11.2017
  • Regulatory management of all change requests in NTO Anti-Infectives
  • First line support of TechOps, QA and project teams on all regulatory questions; secure early alignment on regulatory topics
  • Evaluation of multi product, site and product or non-product specific change requests
  • Training of other departments on regulatory topics
  • Representative of MS&T and DRA in improvement processes at the manufacturing site


Accomplishments:

  • Tackled backlog of change requests; strengthen regulatory position within Technical Operations; Author of many lean proposals and solutions

Regulatory Affairs Manager

KRKA
11.2011 - 12.2016
  • Preparation and implementation of regulatory strategy for individual product in EU
  • Leading new MRP/DCP/CP procedures
  • Communication with national authorities, EMA
  • Submission of PIP waivers to EMA
  • Preparation of strategy, submission and leading national registrations in France and coordination between HQ and Country Office in France


Accomplishments:

  • Successfully led more than 10 DCP/MRP/CP procedures for new generic projects (approx 2 procedures per year).
  • Participated in 3 different Scientific advices at DE, FR and HR authority

Education

Master of Science - Pharmacy

Faculty of Pharmacy, University of Ljubljana
Ljubljana, Slovenia
09-2011

Skills

  • CMC Regulatory Affairs Biosimilars
  • CMC Regulatory Affairs Small Molecules - Generics
  • Regulatory Affairs
  • Drug Development Biosimilars/Generics
  • People’s management
  • Project management
  • Due Diligence Biosimilars

Languages

Slovenian
Native language
English
Advanced
C1
German
Upper intermediate
B2

Timeline

Due Diligence Director Biopharma - Rotation

Sandoz
07.2024 - 01.2025

RA CMC Associate Director Biosimilars

Sandoz
10.2022 - Current

Head Development Regulatory Center

Sandoz
02.2020 - 10.2022

Head of Regulatory New Submissions

Sandoz
11.2017 - 02.2020

CMC facilitator/Regulatory Specialist

Novartis
12.2016 - 11.2017

Regulatory Affairs Manager

KRKA
11.2011 - 12.2016

Master of Science - Pharmacy

Faculty of Pharmacy, University of Ljubljana
Miloš Repše